Ataxin-2 promotes apoptosis of human neuroblastoma cells

Oncogene

Volumn 22, Issue 3, 2003, Pages 401-411

  Wiedemeyer, Ruprecht ^a   Westermann, Frank ^a   Wittke, Isabel ^a   Nowock, Joachim ^b   Schwab, Manfred ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Amplification; Apoptosis; Ataxin 2; MYCN; Neuroblastoma; SCA2

Indexed keywords

ATAXIN 2; PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE AMPLIFICATION; GENE CONTROL; GENETIC CODE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MUTANT; NEUROBLASTOMA; ONCOGENE; ONCOGENE MYCN; ONCOGENE SCA2; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; SENSITIZATION; WILD TYPE;

AMINO ACID CHLOROMETHYL KETONES; APOPTOSIS; CASPASES; CYSTEINE PROTEINASE INHIBITORS; ENZYME ACTIVATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MUTATION; NERVE TISSUE PROTEINS; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PEPTIDES; PROTEINS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0037461902     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206150     Document Type: Article

References (38)

1. Annicchiarico-Petruzzelli M, Bernassola F, Lovat PE, Redfern CP, Pearson AD and Melino G. (2001). Med. Pediatr. Oncol., 36, 115-117.
2. Bernassola F, Scheuerpflug C, Herr I, Krammer PH, Debatin KM and Melino G. (1999). Cell Death Differ., 6, 652-660.
3. Berthold F, Burdach S, Kremens B, Lampert F, Niethammer D, Riehm H, Ritter J, Treuner J, Utsch S and Zieschang J. (1990). Klin. Paediatr., 202, 262-269.
4. Berthold F and Hero B. (2000). Drugs, 59, 1261-1277.
5. Boehm U, Klamp T, Groot M and Howard JC (1997). Annu. Rev. Immunol., 15, 749-795.
6. Boon K, Caron HN, van Asperen R, Valentijn L, Hermus MC, van Sluis P, Roobeek L, Weis I, Voute PA, Schwab M and Versteeg R. (2001). EMBO J., 20, 1383-1393.
7. Catchpoole DR and Lock RB (2001). Eur. J. Cancer, 37, 2217-2221.
8. Cohen O, Feinstein E and Kimchi A. (1997). EMBO J., 16, 998-1008.
9. de Falco G and Giordano A. (1998). J. Cell Physiol., 177, 501-506.
10. Eggert A, Grotzer MA, Zuzak TJ, Wiewrodt BR, Ho R, Ikegaki N and Brodeur GM (2001). Cancer Res., 61, 1314-1319.
11. Estrada R, Galarraga J, Orozco G, Nodarse A and Auburger G. (1999). Acta. Neuropathol. (Berl.), 97, 306-310.
12. Foghsgaard L, Wissing D, Mauch D, Lademann U, Bastholm L, Boes M, Elling F, Leist M and Jaattela M. (2001). J. Cell Biol., 153, 999-1010.
13. Fulda S, Kufer MU, Meyer E, van Valen F, Dockhorn-Dworniczak B and Debatin KM (2001). Oncogene, 20, 5865-5877.
14. Fulda S, Lutz W, Schwab M and Debatin KM (1999). Oncogene, 18, 1479-1486.
15. Gil J and Esteban M. (2000). Oncogene, 19, 3665-3674.
16. Green DR. (2000). Cell., 102, 1-4.
17. Huynh DP, Figueroa K, Hoang N and Pulst SM. (2000). Nat. Genet., 26, 44-50.
18. Ikeda H, Hirato J, Akami M, Suzuki N, Takahashi A, Kuroiwa M and Matsuyama S. (1996). Am. J. Surg. Pathol., 20, 649-655.
19. Imbert G, Saudou F, Yvert G, Devys D, Trottier Y, Garnier JM, Weber C, Mandel JL, Cancel G, Abbas N, Durr A, Didierjean O, Stevanin G, Agid Y and Brice A. (1996). Nat. Genet., 14, 285-291.
20. Johnstone RW, Ruefli AA and Lowe SW. (2002). Cell, 108, 153-164.
21. Leone G, Sears R, Huang E, Rempel R, Nuckolls F, Park CH, Giangrande P, Wu L, Saavedra HI, Field SJ, Thompson MA, Yang H, Fujiwara Y, Greenberg ME, Orkin S, Smith C and Nevins JR. (2001). Mol. Cell, 8, 105-113.
22. Lutz W, Fulda S, Jeremias I, Debatin KM and Schwab M. (1998). Oncogene, 17, 339-346.
23. Lutz W, Stohr M, Schurmann J, Wenzel A, Lohr A and Schwab M. (1996). Oncogene, 13, 803-812.
24. Mac SM, D'Cunha CA and Farnham PJ. (2000). Mol. Carcinogen., 29, 76-86.
25. Muller H, Bracken AP, Vernell R, Moroni MC, Christians F, Grassilli E, Prosperini E, Vigo E, Oliner JD and Helin K. (2001). Genes Dev., 15, 267-285.
26. Nakagawara A, Nakamura Y, Ikeda H, Hiwasa T, Kuida K, Su MS, Zhao H, Cnaan A and Sakiyama S. (1997). Cancer Res., 57, 4578-4584.
27. Nechiporuk T, Huynh DP, Figueroa K, Sahba S, Nechiporuk A and Pulst SM. (1998). Hum. Mol. Genet., 7, 1301-1309.
28. Pritchard J and Hickman JA. (1994). Lancet, 344, 869-870.
29. Pulst SM, Nechiporuk A, Nechiporuk T, Gispert S, Chen XN, Lopes-Cendes I, Pearlman S, Starkman S, Orozco-Diaz G, Lunkes A, DeJong P, Rouleau GA, Auburger G, Korenberg JR, Figueroa C and Sahba S. (1996). Nat. Genet., 14, 269-276.
30. Sanpei K, Takano H, Igarashi S, Sato T, Oyake M, Sasaki H, Wakisaka A, Tashiro K, Ishida Y, Ikeuchi T, Koide R, Saito M, Sato A, Tanaka T, Hanyu S, Takiyama Y, Nishizawa M, Shimizu N, Nomura Y, Segawa M, Iwabuchi K, Eguchi I, Tanaka H, Takahashi H and Tsuji S. (1996). Nat. Genet., 14, 277-284.
31. Savelyeva L and Schwab M. (2001). Cancer Lett., 167, 115-123.
32. Stark GR, Kerr IM, Williams BR, Silverman RH and Schreiber RD. (1998). Annu. Rev. Biochem., 67, 227-264.
33. Teitz T, Lahti JM and Kidd VJ. (2001). J. Mol. Med., 79, 428-436.
34. Teitz T, Wei T, Valentine MB, Vanin EF, Grenet J, Valentine VA, Behm FG, Look AT, Lahti JM and Kidd VJ. (2000). Nat. Med., 6, 529-535.
35. van Golen CM, Castle VP and Feldman EL (2000). Cell Death Differ., 7, 654-665.
36. van Golen CM, Schwab TS, Ignatoski KM, Ethier SP and Feldman EL. (2001). Cell Growth Differ., 12, 371-378.
37. Varfolomeev EE, Schuchmann M, Luria V, Chiannilkulchai N, Beckmann JS, Mett IL, Rebrikov D, Brodianski VM, Kemper OC, Kollet O, Lapidot T, Soffer D, Sobe T, Avraham KB, Goncharov T, Holtmann H, Lonai P and Wallach D. (1998). Immunity, 9, 267-276.
38. Wittke I, Wiedemeyer R, Pillmann A, Savelyeva L, Westermann F and Schwab M. (2002). Submitted.